New drug cocktail aims to wipe out rare, aggressive breast cancer before surgery
Disease control
Recruiting now
This phase II trial is testing whether combining two drugs—trastuzumab deruxtecan (Enhertu) and durvalumab—given before surgery can eliminate cancer in people with stage III inflammatory breast cancer that has HER2 protein. The study will enroll 63 participants and measure how ma…
Phase: PHASE2 • Sponsor: Filipa Lynce, MD • Aim: Disease control
Last updated Jun 26, 2026 19:08 UTC